According to internal documents, the pharmaceutical company Wyeth "paid ghostwriters to produce medical journal articles favorable to its female hormone replacement therapy Prempro." As early as 1997, Wyeth paid the "medical writing firm" DesignWrite to publish favorable journal articles about Prempro under academics' names.
The Canadian Association of University Teachers has strongly condemned a new lawsuit by the Apotex pharmaceutical company against Dr. Nancy Olivieri. As a liver specialist at the University of Toronto, Olivieri first came under attack from Apotex in 1996 when she notified her patients that she had detected toxic side effects while conducting an Apotex-sponsored study of the company's drug, deferiphone.
Biopure, a company that makes blood substitutes, is suing scientist Charles Natanson for defamation after he published a critical review in the Journal of the American Medical Association. Nature magazine has condemned the lawsuit.
Science reporting "is more and more the direct product of PR shops," according to Charles Petit, a veteran science reporter who runs MIT’s online Knight Science Journalism Tracker.